Clinical Trials · NCT07845500
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Pfizer
- Enrollment
- 660
- Start date
- Oct 2026
- Locations
- 8 sites, United States
- Primary endpoint
- Percent change from baseline in body weight